rs17760877

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.1125+9206T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0937 in 152,226 control chromosomes in the GnomAD database, including 829 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.094 ( 829 hom., cov: 33)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.324

Publications

4 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.1125+9206T>G
intron
N/ANP_000825.2
GRIN2B
NM_001413992.1
c.1125+9206T>G
intron
N/ANP_001400921.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.1125+9206T>G
intron
N/AENSP00000477455.1
GRIN2B
ENST00000630791.3
TSL:5
c.1125+9206T>G
intron
N/AENSP00000486677.3
GRIN2B
ENST00000636855.1
TSL:5
n.23+9206T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0937
AC:
14253
AN:
152108
Hom.:
826
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0358
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.144
Gnomad EAS
AF:
0.0104
Gnomad SAS
AF:
0.111
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.108
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0937
AC:
14265
AN:
152226
Hom.:
829
Cov.:
33
AF XY:
0.0934
AC XY:
6950
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0358
AC:
1488
AN:
41552
American (AMR)
AF:
0.129
AC:
1969
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.144
AC:
498
AN:
3462
East Asian (EAS)
AF:
0.0104
AC:
54
AN:
5180
South Asian (SAS)
AF:
0.110
AC:
530
AN:
4810
European-Finnish (FIN)
AF:
0.108
AC:
1149
AN:
10612
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.120
AC:
8157
AN:
68008
Other (OTH)
AF:
0.111
AC:
234
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
663
1326
1990
2653
3316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0997
Hom.:
99
Bravo
AF:
0.0959
Asia WGS
AF:
0.0760
AC:
264
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.1
DANN
Benign
0.83
PhyloP100
0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17760877; hg19: chr12-13819473; API